|
| Study | Study design | Patients | Methods | Follow-up | Significant findings related to visual field progression |
|
| Schumann et al. [17] | Retrospective | POAG () with progressive visual field defects | VFI mean defect over time | 50.1 ± 19.4 months | Mean blood flow velocities in the CRA, PSV, and RI in the OA |
|
|
Gherghel et al. [18] | Retrospective | POAG ( with progressive visual field defects, matched patients with stable disease) | Deepening of existing scotoma, expansion of existing scotoma, and fresh scotoma | 5.3 ± 2.2 years | EDV in the CRA |
|
|
Martínez and Sánchez [19] | Prospective | POAG (, 23 patients with progressive visual field defects) | Deepening of existing scotoma, expansion of existing scotoma, and fresh scotoma | 36 months | RI in the OA and SPCAs |
|
|
Satilmis et al. [20] | Retrospective | POAG ( with progressive visual field defects) | Deepening of existing scotoma, expansion of existing scotoma, fresh scotoma, and VFI mean defect over time | 4.3 ± 1.6 years | EDV in the CRA |
|
| Galassi et al. [21] | Retrospective | POAG (, 18 with progressive visual field defects) | Progressive visual field defect recorded in at least 3 consecutive examinations | Up to 7 years | EDV and RI in the OA |
|
| Calvo et al. [22] | Prospective | Glaucoma suspects (, 36 with progressive disease) | Color coded Moorfields Regression Analysis (MRA) in confocal laser scanning system | 48 months | RI > 0.75 in the CRA |
|
| Zeitz et al. [23] | Prospective | Glaucoma (, 12 with progressive visual field defects) | Increase in the cup-disc ratio of the optic disc and increase in MD | 295 ± 18 days | PSV and EDV in the PCAs |
|
| Jimenez-Aragon et al. [24] | Prospective | POAG (, 12 with progressive visual field defects) | Color coded Moorfields Regression Analysis (MRA) in confocal laser scanning system | 5 years | RI in the OA and CRA |
|
| Kuerten et al. [25] | Retrospective | NTG () | VFI progression per year | 7.6 ± 4.1 years | PSV of the CRA, RI of NPCA |
|
